University Hospital Regensburg
52
7
9
24
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
9.6%
5 terminated/withdrawn out of 52 trials
82.8%
-3.7% vs industry average
10%
5 trials in Phase 3/4
4%
1 of 24 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (52)
Widening Aims and Giving Patients a Voice for Expanded Structures in Breast Cancer Care Jointly Developed by Patients and Physicians
Role: collaborator
Preconditioning of Tumor, Tumor Microenvironment and the Immune System to Immunotherapy
Role: collaborator
Gustabor Phase 1 - AI-based Creation of a Nutritional Plan to Compensate for Chemotherapy-induced Taste Disorders
Role: collaborator
PROTon Pump Inhibitors and Stent OCclusion Rate Of Lumen Apposing Metal Stents
Role: collaborator
Juxtarenal Aortic Aneurysm
Role: collaborator
Patient-centred Deprescribing of Psychotropic, Sedative and Anticholinergic Medication in Elderly Patients With Polypharmacy
Role: collaborator
Integrated Analysis of Therapy Response and Resistence in Embryonal Tumors and Gliomas
Role: lead
Adjusted High-dose Chemotherapy With Autologous Stem Cell Transplant vs. Conventional Immunochemotherapy in Elderly PCNSL Patients
Role: collaborator
Treatment Evaluation of Neuromodulation for Tinnitus (TENT-A)
Role: collaborator
Cell Therapy for Immunomodulation in Kidney Transplantation
Role: collaborator
Registry on the Treatment of Central and Complex Sleep-Disordered Breathing With Adaptive Servo-Ventilation
Role: collaborator
Study on the Effectiveness of Berlin Dissexuality Therapy as Part of the Model Project in Accordance With §65d SBG V
Role: collaborator
Molecular Mechanisms in Malignant Lymphoma- Predict (MMML Predict)
Role: collaborator
Low-dose AZA, Pioglitazone, ATRA Versus Standard-dose AZA in Patients >=60 Years With Refractory AML
Role: lead
Reduction of SystemiC Inflammation After Ischemic Stroke by Intravenous DNase Administration (ReSCInD)
Role: collaborator
Impact of Surgical Mask, FFP2 Mask and FFP3 Mask (With and Without Exhalation Valve) on Exercise Tolerance and Blood Gas Parameters of Patients With Known Lung Disease and Long-term Oxygen Therapy
Role: lead
Quality Improvement Project - "My Logbook! - I Know my Way Around!"; ("Mein Logbuch - Ich Kenne Mich Aus!")
Role: collaborator
Dual Guidance Structure for Evaluation of Patients With Unclear Diagnosis in Centers for Rare Diseases
Role: collaborator
Acalabrutinib in Combination With R-miniCHOP in Older Adults With Untreated Diffuse Large B-Cell Lymphoma
Role: collaborator
UNification of Treatments and Interventions for TInnitus Patients - Randomized Clinical Trial (UNITI-RCT)
Role: collaborator